Very well written multiple PR’s this morning that show clear superior benefit of leronlimab vs (SOC. I think the market will react well to these PR’s much talk from the shirts about shaking the tree but I don’t think many leaves fall and could end up being a nice day overall. They have t done much damage in Germany down 12% and that was before all these PR’s hit also on low volume in which shorts can manipulate easier the other countries markets follow US market as well so if
We Go up in a.m they would follow.